MedTrace Logo

S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer

NCT02728804 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 380

Last updated 2023-01-26

Study results available
· View outcomes & findings →

Summary

This clinical trial studies the use of the financial impact assessment tool in patients with colorectal cancer that has spread from the primary site to other places in the body. Gathering information about patients with colorectal cancer over time may help doctors better understand the financial impact of cancer and help patients avoid financial problems during treatment.

Conditions

  • Stage IVA Colon Cancer
  • Stage IVA Rectal Cancer
  • Stage IVB Colon Cancer
  • Stage IVB Rectal Cancer

Interventions

OTHER

Quality-of-Life Assessment

Complete questionnaire

OTHER

Questionnaire Administration

Complete questionnaires

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • SWOG Cancer Research Network

    lead NETWORK

Principal Investigators

  • Veena Shankaran · SWOG Cancer Research Network

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-22
Primary Completion
2020-04-15
Completion
2020-11-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02728804 on ClinicalTrials.gov